MedCap AB (publ) Asset Resilience Ratio
MedCap AB (publ) asset resilience ratio. MedCap AB (publ) (MCAP) has an Asset Resilience Ratio of 14.21% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See MCAP cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of MedCap AB (publ) (2016–2025)
Asset resilience ratio of MedCap AB (publ) from 2016 to 2025. This chart shows how MedCap AB (publ)'s Asset Resilience Ratio has changed over time. Read MCAP total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down MedCap AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see MedCap AB (publ) assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr370.40 Million | 14.21% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr370.40 Million | 14.21% |
Asset Resilience Insights
- Moderate Liquidity: MedCap AB (publ) has 14.21% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
MedCap AB (publ) Industry Peers by Asset Resilience Ratio
Compare MedCap AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
MedCap AB (publ) Asset Resilience Ratio by Year (2016–2025)
MedCap AB (publ) asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for MedCap AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 14.21% | Skr370.40 Million ≈ $39.86 Million |
Skr2.61 Billion ≈ $280.45 Million |
-4.37pp |
| 2024-12-31 | 18.58% | Skr370.10 Million ≈ $39.83 Million |
Skr1.99 Billion ≈ $214.31 Million |
+7.26pp |
| 2023-12-31 | 11.32% | Skr188.20 Million ≈ $20.25 Million |
Skr1.66 Billion ≈ $178.88 Million |
-5.20pp |
| 2022-12-31 | 16.53% | Skr236.20 Million ≈ $25.42 Million |
Skr1.43 Billion ≈ $153.82 Million |
+4.58pp |
| 2021-12-31 | 11.95% | Skr139.70 Million ≈ $15.03 Million |
Skr1.17 Billion ≈ $125.86 Million |
-1.60pp |
| 2020-12-31 | 13.55% | Skr146.50 Million ≈ $15.77 Million |
Skr1.08 Billion ≈ $116.37 Million |
+11.10pp |
| 2019-12-31 | 2.45% | Skr20.60 Million ≈ $2.22 Million |
Skr842.30 Million ≈ $90.64 Million |
+0.23pp |
| 2018-12-31 | 2.21% | Skr14.80 Million ≈ $1.59 Million |
Skr668.90 Million ≈ $71.98 Million |
-8.01pp |
| 2017-12-31 | 10.22% | Skr61.33 Million ≈ $6.60 Million |
Skr600.20 Million ≈ $64.59 Million |
+2.66pp |
| 2016-12-31 | 7.56% | Skr42.59 Million ≈ $4.58 Million |
Skr563.16 Million ≈ $60.61 Million |
-- |
About MedCap AB (publ)
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; an… Read more